
Emerald
Comprehensive health screenings with 110 biomarker tests, personalized plans, and actionable goals for optimized long-term health.
Date | Investors | Amount | Round |
---|---|---|---|
* | £625k | Seed | |
Total Funding | 000k |
Related Content
Emerald operates in the health diagnostics market, offering comprehensive health screenings that go beyond typical annual checkups. The company provides a Baseline Health Check that includes 110 lab tests at a fraction of the usual cost, focusing on biomarkers to deliver unparalleled insights into an individual's health. Clients can integrate their lifestyle, family history, fitness data, and previous results into a single platform, allowing for a holistic view of their health. Emerald's business model revolves around personalized health plans, which are designed to help clients make informed long-term health decisions. The service is particularly beneficial for individuals seeking to optimize their health and stay ahead of potential diseases. By visualizing data and setting personalized, actionable goals, Emerald incentivizes clients to lead active, healthy lives. The company generates revenue through its health screening services and personalized health plans, targeting health-conscious individuals who value detailed and personalized health insights. Keywords: health screenings, biomarkers, personalized plans, diagnostics, lifestyle integration, fitness data, health optimization, disease prevention, actionable goals, client-focused.